Interpretation of the UK screening and treatment of retinopathy of prematurity updated 2022 guidelines
10.7499/j.issn.1008-8830.2311073
- VernacularTitle:英国早产儿视网膜病变的筛查和治疗指南2022更新版解读
- Author:
Xiao-Yan DONG
1
;
Jia-Zhi LI
;
Ke-Ren LUO
;
Jun TANG
;
De-Zhi MU
Author Information
1. 四川大学华西第二医院儿科/出生缺陷与相关妇儿疾病教育部重点实验室,四川成都 610041
- Keywords:
Retinopathy;
Screening;
Treatment;
Guideline;
Premature infant
- From:
Chinese Journal of Contemporary Pediatrics
2024;26(5):437-443
- CountryChina
- Language:Chinese
-
Abstract:
The UK screening and treatment of retinopathy of prematurity(ROP)updated 2022 guidelines were developed by a multidisciplinary guideline development group from the Royal College of Paediatrics and Child Health and the Royal College of Ophthalmologists,following the standards of the National Institute for Health and Care Excellence.They were published on the websites of the Royal College of Paediatrics and Child Health and the Royal College of Ophthalmologists in March 2022,and formally published in Early Human Development in March 2023.The guidelines provide evidence-based recommendations for the screening and treatment of ROP.The most significant change in the 2022 updated version compared to the previous guidelines is the lowering of the gestational age screening criterion to below 31 weeks.The treatment section covers treatment indications,timing,methods,and follow-up visits of ROP.This article interprets the guidelines and compares them with ROP guidelines/consensus in China,providing a reference for domestic peers.
